Insider Trading15 Jun 2026, 07:30 pm
AstraZeneca Pharma India Closes Trading Window
AI Summary
AstraZeneca Pharma India Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from June 16, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.
Key Highlights
- Trading window closed from June 16, 2026.
- Reopening after 48 hours of Q2 FY27 results declaration.
- Compliance with SEBI Insider Trading Regulations.
- Standard procedure to prevent insider trading.
Price Impact
More from ASTRAZEN